BioCorRx adopts 2022 Omnibus Plan authorizing 695,000 shares for equity incentives

BioCorRx Inc.

Board approved 2022 Omnibus Securities and Incentive Plan on April 22, 2022; replaces 2018 plan.
Plan reserves 695,000 shares of common stock for future equity awards.
Non-employee director annual compensation cap set at $300,000 (equity + cash).
Outstanding 2018 plan awards continue; forfeited shares become available under 2022 plan.
Plan permits options, restricted stock, units, performance units, SARs and distribution equivalent rights.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.